Identifying Non-Steroidal Anti-Inflammatory Drug (NSAID) Users Among People with Osteoarthritis Through Administrative and Clinician-Reported Data – A Validation Study of 116,162 Patients

References

• Long H, Liu Q, Yin H, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74(7):1172–1183. doi:10.1002/art.42089
   PubMed Web of Science ®Google Scholar
• Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a lancet commission. Lancet. 2020;396(10264):1711–1712. doi:10.1016/s0140-6736(20)32230-3
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. doi:10.1016/j.joca.2019.06.011
   PubMed Web of Science ®Google Scholar
• Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568–578. doi:10.1001/jama.2020.22171
   PubMed Web of Science ®Google Scholar
• Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pract. 2012;12(7):550–560. doi:10.1111/j.1533-2500.2012.00532.x
   PubMed Web of Science ®Google Scholar
• Adams RJ, Appleton SL, Gill TK, Taylor AW, Wilson DH, Hill CL. Cause for concern in the use of non-steroidal anti-inflammatory medications in the community-a population-based study. BMC Fam Pract. 2011;12(1):70. doi:10.1186/1471-2296-12-70
   PubMedGoogle Scholar
• Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology. 2014;53(5):937–947. doi:10.1093/rheumatology/ket463
   PubMed Web of Science ®Google Scholar
• Duong M, Salvo F, Pariente A, et al. Usage patterns of ‘over-the-counter’ vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol. 2014;77(5):887–895. doi:10.1111/bcp.12239
   PubMed Web of Science ®Google Scholar
• Jonsson T, Eek F, Dell’Isola A, Dahlberg LE, Ekvall Hansson E. The better management of patients with osteoarthritis program: outcomes after evidence-based education and exercise delivered nationwide in Sweden. PLoS One. 2019;14(9):e0222657. doi:10.1371/journal.pone.0222657
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808. doi:10.1136/bmj.39335.541782.AD
   PubMed Web of Science ®Google Scholar
• The National Board of Health and Welfare. Nationella riktlinjer för rörelseorganens sjukdomar 2012 [Elektroniska resurser]: Osteoporos, artros, inflammatorisk ryggsjukdom och ankyloserande spondylit, psoriasisartrit och reumatoid artrit: Stöd för styrning och ledning [National guidelines for musculoskeletal diseases 2012 [Electronic resources]: Osteoporosis, osteoarthritis, inflammatory back disease and ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis: Support for governance and management]. Socialstyrelsen; 2012.
   Google Scholar
• Dell’Isola A, Turkiewicz A, Jönsson T, Rolfson O, Dahlberg L, Englund M. The role of pain and walking difficulties in shaping willingness to undergo joint surgery for osteoarthritis: data from the Swedish BOA register. Osteoarthr Cartil Open. 2021;3(2):100157. doi:10.1016/j.ocarto.2021.100157
   PubMedGoogle Scholar
• Dell’Isola A, Jonsson T, Ranstam J, Dahlberg LE, Ekvall Hansson E. Education, home exercise, and supervised exercise for people with hip and knee osteoarthritis as part of a nationwide implementation program: data from the better management of patients with osteoarthritis registry. Arthritis Care Res. 2020;72(2):201–207. doi:10.1002/acr.24033
   Web of Science ®Google Scholar
• Dell’Isola A, Jonsson T, Nero H, Eek F, Dahlberg L. Factors associated with the outcome of a first-line intervention for patients with hip or knee osteoarthritis or both: data from the BOA register. Phys Ther. 2020;100(10):1771–1781. doi:10.1093/ptj/pzaa113
   PubMed Web of Science ®Google Scholar
• World Health Organization, Regional Office for E, European Observatory on Health S, Policies; et al. Health systems in transition: Sweden. Health Syst Transit. 2005;7(4):1.
   Google Scholar
• Hakonsen H, Wangberg M, Alani D, Hedenrud T. Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers. J Pharm Policy Pract. 2020;13(1):60. doi:10.1186/s40545-020-00269-5
   PubMed Web of Science ®Google Scholar
• Dell’Isola A, Turkiewicz A, Zhang W, et al. Does osteoarthritis modify the association between NSAID use and risk of comorbidities and adverse events? Osteoarthr Cartil Open. 2022;4(2):100253. doi:10.1016/j.ocarto.2022.100253
   PubMedGoogle Scholar
• Seed P. DIAGT: stata module to report summary statistics for diagnostic tests compared to true disease status; 2010.
   Google Scholar
• Knoop J, van Tunen J, van der Esch M, et al. Analgesic use in patients with knee and/or hip osteoarthritis referred to an outpatient center: a cross-sectional study within the Amsterdam osteoarthritis cohort. Rheumatol Int. 2017;37(10):1747–1755. doi:10.1007/s00296-017-3785-3
   PubMed Web of Science ®Google Scholar
• Roos EM, Gronne DT, Skou ST, et al. Immediate outcomes following the GLA:D(R) program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or Hip osteoarthritis. Osteoarthritis Cartilage. 2021;29(4):502–506. doi:10.1016/j.joca.2020.12.024
   PubMed Web of Science ®Google Scholar
• Selcuk H, Roos EM, Gronne DT, Ernst MT, Skou ST. Agreement between self-reported information and administrative data on comorbidities, imaging and treatment in Denmark - a validation study of 38,745 patients with knee or hip osteoarthritis. Clin Epidemiol. 2021;13:779–790. doi:10.2147/CLEP.S309364
   PubMed Web of Science ®Google Scholar
• Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. perspective. Front Public Health. 2017;2017:5. doi:10.3389/fpubh.2017.00307
   Google Scholar
• Kingsbury SR, Hensor EM, Walsh CA, Hochberg MC, Conaghan PG. How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the osteoarthritis initiative. Arthritis Res Ther. 2013;15(5):R106. doi:10.1186/ar4286
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–499. doi:10.1016/j.joca.2010.01.013
   PubMed Web of Science ®Google Scholar
• Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet. 2008;371(9608):270–273. doi:10.1016/s0140-6736(08)60137-3
   PubMed Web of Science ®Google Scholar
• Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145–1153. doi:10.1016/j.joca.2013.03.018
   PubMed Web of Science ®Google Scholar